Think you are hung up on semantics!
The risk outcomes based on thousands of cases indicate there is very little difference between a t3a and a t2 (or a t1 for that matter).
The big jumps in risk come with t3a+ or high Gleason scores regardless of staging.
You can see this by playing around with the various scores on the nomogram.
That's just the nature of prostate cancer and the fact it is normally slow growing.
Edited by member 11 Feb 2023 at 11:32
| Reason: Not specified